Answer
Glofitamab’s effective half-life in the linear phase, after time-varying clearance becomes negligible, is 7.92 days (geometric mean; 95% CI: 4.69–11.90), based on population pharmacokinetic analysis.
Sources for this answer
- Columvi 2.5 mg, 10 mg concentrate for solution for infusionRoche Products Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 6Document updated
Sources checked